SA
VBIO

Sanctuary Advisors’s Valion Bio VBIO Stock Holding History

Sanctuary Advisors’s Portfolio VBIO Stock Details VBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$54.2K Buy
+61,205
New +$62.6K ﹤0.01% 2486

Other funds holding VBIO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return

Sanctuary Advisors's VBIO Position: Q1 2026 in Review

Sanctuary Advisors opened a new position in Valion Bio (VBIO) in Q1 2026: 61,205 shares worth $54.2K. The stake represents ﹤0.01% of the portfolio and ranks #2486 among its holdings.

9 funds tracked by Wall St. Rank hold VBIO as of Q1 2026.

  • Sanctuary Advisors held 61,205 shares of Valion Bio worth $54.2K as of Q1 2026.
  • Valion Bio was a new Sanctuary Advisors position in Q1 2026.
  • Valion Bio made up ﹤0.01% of Sanctuary Advisors's portfolio in Q1 2026, its #2486 holding.
  • 9 funds tracked by Wall St. Rank held Valion Bio as of Q1 2026.

Based on Sanctuary Advisors's 13F filing for Q1 2026, filed 5 May 2026.